News

Benzinga.com15d
Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
Shares of argenx SE ARGX rose sharply in today's pre-market trading after the company announced the FDA approval of VYVGART Hytrulo prefilled syringe for self-injection in generalized myasthenia ...
The Pharma Letter15d
Palatin Technologies faces delisting over equity shortfall
US biopharma company Palatin Technologies (NYSE American: PTN) is at risk of being removed from the NYSE American exchange after failing to meet minimum stockholders' equity requirements. The exchange ...
Ziua De Vest15d
Tradiție și spiritualitate: cea de-a XIII-a ediție a evenimentului „Toaca la Lugoj”
Duminică, 13 aprilie, în Ziua Floriilor, la Biserica Ortodoxă „Sfântul Ierarh Iosif cel Nou de la Partoș” din Dealul Viilor, va alea loc cea de-a XIII-a ediție a evenimentului „Toaca la Lugoj”. „În ...
EVZ15d
Americanii scanează comoara de la Budureasa, zăcământul strategic de brucit exploatat cu fonduri UE
Sunt semne pentru deblocarea exploatării de brucit din Budureasa Bihor. Firma cu acționariat american, Verde Magnesium, care a concesionat licența de exploatare, a depus un memoriu la noua Direcție ...
Le Lézard15d
Palatin to Present Positive Phase 2b Data for Melanocortin Agonist in Diabetic Kidney Disease at the National Kidney Foundation Spring Meeting
About Palatin Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted ...
Seeking Alpha15d
Palatin Technologies, Inc. Announces Receipt of NYSE American Notice of Delisting and Intention to Appeal
CRANBURY, N.J., April 10, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of ...
Le Lézard15d
NYSE American to Commence Delisting Proceedings Against Palatin Technologies, Inc. (PTN)
NYSE American LLC ("NYSE American" or the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Palatin Technologies ...
Nasdaq15d
Palatin Technologies, Inc. Announces Receipt of NYSE American Notice of Delisting and Intention to Appeal
CRANBURY, N.J., April 10, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (the "Company") (NYSE American:PTN), a biopharmaceutical company developing first-in-class ...
Investing15d
Palatin reports promising kidney disease treatment results
CRANBURY, N.J. - Palatin Technologies, Inc. (NYSE American: PTN), a small-cap biotech company with a market capitalization of $11.5 million, revealed significant clinical improvements in patients with ...
Stiri15d
Ciobanul din Prahova care tot face descoperiri ieșite din comun. De data aceasta, ce a găsit are 5.000 de ani | FOTO
"Aflat la nord de Valea Semanului, cartier al oraşului Urlaţi (Prahova), Vârful Scoruş este dealul cu cea mai mare altitudine din ... Autoritățile de la Roma se pregătesc pentru un aflux copleșitor de ...
Investing15d
Palatin Technologies faces potential NYSE American delisting
CRANBURY, N.J. - Palatin Technologies, Inc. (NYSE American:PTN), a biopharmaceutical company currently trading at $0.43 per share, has been notified by NYSE American LLC of the intention to delist ...